NEJM Evidence Issues Research Articles in March 2023 Edition
March 01, 2023
March 01, 2023
WALTHAM, Massachusetts, March 1 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its March 2023 edition:
Original Articles:
* Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection
* Lung Function of Preterm Children Parsed by a Polygenic Risk Score for Adult COPD
. . .
Original Articles:
* Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection
* Lung Function of Preterm Children Parsed by a Polygenic Risk Score for Adult COPD
. . .
